Lupus anticoagulant (LA)
Anti beta2 glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant like activity enhance the beta2GPI binding to phospholipids
10
Overt increase in lupus anticoagulant level in HIV patients co-infected with pulmonary Mycobacterium tuberculosis infection: A prospective cohort study
6
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
11
Localization of the apoptosis inducing activity of lupus anticoagulant in an annexin V binding antibody subset
10
Acquired factor VIII inhibitor and lupus anticoagulant presenting with prolonged aPTT: a case report
6
Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2 glycoprotein I
6
Thrombin generation as marker to estimate thrombosis risk in patients with abnormal test results in lupus anticoagulant routine diagnostics
7
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant
13
Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant
7
Further investigations of lupus anticoagulant interference in a functional assay for tissue factor pathway inhibitor
5
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity Mechanism of a lupus anticoagulant
10
Profile of patients with Thrombosis evaluated in a Tertiary Care Center.
91
Final Diagnosis of Pediatric Patients with Prolonged in Activated Partial Thromboplastin Time Preoperative Study
7
LA and aCL in an unselected popula- tion of children with idiopathic cerebral ischemia and to compare the clinical and radiological features observed in aPL-positive and aPL-negative patients. PATIENTS AND METHODS
6
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
9
Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy
6
Acquired activated protein C resistance and thrombosis in multiple myeloma patients
6
On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies
9
Anticardiolipin antibodies in unexplained pregnancy loss
107
Current Update on Recurrent Pregnancy Loss.
6